However, unlike in colorectal cancer, we found a substantial number of resistant colonies arise following combination of MEK1/2-JAK2 inhibition in TNBC cell lines, suggesting a complexity in response in which TNBC cells are able to bypass combined inhibition of these two pathways to survive. The gene discussed is JAK2; the disease is colorectal cancer.